Udo J. Vetter, Chairman of the Board of Trustees of the ICPO Foundation. He is Chairman of the family-owned business Vetter Pharma and brings extensive experience and leadership to the Board of ICPO. Vetter Pharma achieved a turnover of one billion euros in 2023 with 6,300 employees. His many years in the pharmaceutical industry and his commitment to innovative solutions make him an essential driving force for the development of the ICPO Foundation. In 2003, he established the investment company UV-Cap GmbH & Co. KG. He holds a membership at the Advisory Group GPMLF of the International Society of Pharmaceutical Engineers (ISPE). Furthermore, he chairs the Isotope Technologies Munich SE (ITM) board and sits on the Board of Gland Pharma, India. In 2019, he became President of European Family Businesses (EFB). His strategic foresight and cooperative approach enable the ICPO Foundation's advancement, thus scaling global patient access to radiotheranostics.
